CAI vs TXN · rev $812.0M vs P/E 52, rev $10.29B
Caris Life Sciences, Inc. Common Stock (CAI) versus Texas Instruments Incorporated (TXN) — a side-by-side from cached financials, not a winner call.
Caris Life Sciences, Inc. Common Stock (CAI) is a biotechnology company listed on NASDAQ.
Texas Instruments Incorporated (TXN) is a semiconductors company listed on NASDAQ.
Latest reported CAI revenue for 2025-12-31 was $812.0M. Net income was -$68.1M. Revenue was up 97.0% from 2024-12-31 to 2025-12-31. CAI currently screens at market cap $5.22B.
Latest reported TXN revenue for 2026-06-30 was $10.29B. Net income was $3.52B. TXN currently screens at market cap $274.74B and trailing P/E 51.7.
CAI currently screens at market cap $5.22B. TXN currently screens at market cap $274.74B and trailing P/E 51.7.
Not investment advice. Open the CAI and TXN stock pages for the full models.
Not investment advice.